2023 - Research.com Microbiology in United Kingdom Leader Award
Molecular biology, Epstein–Barr virus, Virus, Virology and RNA are his primary areas of study. His Molecular biology research is multidisciplinary, incorporating perspectives in Complementary DNA, Gene expression, Gene, BZLF1 and Binding site. His Epstein–Barr virus research incorporates themes from Burkitt's lymphoma, B cell, Cell cycle, Regulation of gene expression and Lytic cycle.
His work carried out in the field of Virus brings together such families of science as Cyclin A2, Cyclin D2 and Cyclin D. His work deals with themes such as Transfection, Antigen and Lymphoma, which intersect with Virology. His RNA research includes elements of Nuclear protein, Messenger RNA and Protein biosynthesis.
Paul J. Farrell mainly focuses on Molecular biology, Epstein–Barr virus, Virology, Virus and Gene. His Molecular biology study combines topics from a wide range of disciplines, such as RNA, Transcription factor, Promoter, Regulation of gene expression and Transcription. His biological study spans a wide range of topics, including Virus latency, Lytic cycle, Cell growth and Genome.
His Virology research includes themes of Cell culture, Transfection, Burkitt's lymphoma and Gene expression. Paul J. Farrell interconnects Disease and Antigen in the investigation of issues within Virus. His Gene study is concerned with Genetics in general.
His scientific interests lie mostly in Virus, Epstein–Barr virus, Virology, Gene and Molecular biology. His study in Virus is interdisciplinary in nature, drawing from both Innate immune system, microRNA, Disease and Cell biology. The study incorporates disciplines such as Virus latency, Genome and Genetic variation in addition to Epstein–Barr virus.
His research ties Pattern recognition receptor and Virology together. Gene is a subfield of Genetics that Paul J. Farrell explores. His Molecular biology research is multidisciplinary, incorporating elements of Cell culture, In vitro, B cell, Promoter and Transcription.
His primary areas of study are Epstein–Barr virus, Gene, Virus, Virology and Genome. Paul J. Farrell integrates Epstein–Barr virus with Proinflammatory cytokine in his research. His Gene study is concerned with the larger field of Genetics.
His Virus study integrates concerns from other disciplines, such as Protein structure, Disease, Fusion protein and Cell biology. The Virology study combines topics in areas such as STAT3 and STAT protein. His studies examine the connections between Genome and genetics, as well as such issues in Diffuse large B-cell lymphoma, with regards to Sequence and Transformation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
R. Baer;R. Baer;A. T. Bankier;M. D. Biggin;P. L. Deininger.
Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis
Paul J. Farrell;Ken Balkow;Tim Hunt;Richard J. Jackson.
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
M Rowe;D T Rowe;C D Gregory;L S Young.
The EMBO Journal (1987)
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
Daniele Bergamaschi;Milena Gasco;Louise Hiller;Alexandra Sullivan.
Cancer Cell (2003)
Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.
P. J. Farrell;D. T. Rowe;C. M. Rooney;T. Kouzarides.
The EMBO Journal (1989)
EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.
A.J. Sinclair;I. Palmero;G. Peters;P.J. Farrell.
The EMBO Journal (1994)
p53 is frequently mutated in Burkitt's lymphoma cell lines.
P.J. Farrell;G.J. Allan;F. Shanahan;K.H. Vousden.
The EMBO Journal (1991)
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells.
Paul J. Farrell;Robert J. Broeze;Peter Lengyel.
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.
Alexandra Sullivan;Nelofer Syed;Milena Gasco;Daniele Bergamaschi.
Epstein–Barr virus and Burkitt lymphoma
G Brady;Georgina J MacArthur;P J Farrell.
Journal of Clinical Pathology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: